ALT 📋 This session will cover: ✅ How tools like AI and predictive analytics can enable smarter, more integrated approaches to detection and risk assessment, building on biomarker-based screening approaches ✅ What it takes to successfully embed AI into real-world clinical workflows, from primary care to specialist areas. ✅ The major barriers still standing in the way of integrating AI into screening pathways 🎙️ Moderated by: Christophe Hezode, MD, Senior Director in Medical Affairs, Gilead 👥 Panelists: Paula Petrone, Head of the Digital Health Unit at the Barcelona Supercomputing Center, Spain Justus Wolff, Chair of AI Global Metabolic Health Alliance, Management Team Praedigo, Germany 💡 Justus will talk about the implementation process of certified AI as Medical Device for Liver Diseases in Europe Doug Simonetto, Program Director Gastroenterology and Hepatology Fellowship Program at Mayo Clinic, USA